Biota pharmacueticals. Ticker BOTA. Lady analyst mentioned it as a beneficary of the flu epidemic. Low share float. Could take off big.
really? tell me about their IP revenue stream .. and the 182M shares in the OS. lol!
This flu episode will begin to subside.. be over the hump in a few days.
BARDA 231 million grant
NIH grant for drugs fighting super bacteria
HEP C patent ( the one BCRX is fighting for )
Cure for common cold drug. Sucessful stage 2b. Vapendavir.
70 Million Cash. NO DEBT
$112 million market cap.
Yes you really need to research this one. No brainer.
Ticker BOTA. NASDAQ.
Sentiment: Strong Buy
Do your research. Reverse split when they merged with another biotech. They were awarded a 231 million dollar contract by Barta to develop a new generation of flu vacine. They have no debt.